Re: Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, is Not a Surrogate for Overall Survival in Men with Localized Prostate Cancer Treated with Radiation (2021)
Attributed to:
CANCER: Trials with potential global reach and other challenging trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Journal Article/Review
Volume: 205
Parent Publication: JOURNAL OF UROLOGY
Issue: 3
ISSN: 0022-5347